GOLDSMITH MARK A sold RVMD
March 2, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 200 shares of Revolution Medicines, Inc. at $102.08 per share, a transaction worth $20.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$102.08
Total value
$20.4K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after64,424
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Held by Rebecca Goldsmith Revocable Trust.